Skip to content
Araris Biotech AG logo

Araris Biotech AG Alternatives & Competitors

7 companies similar to Araris Biotech AG — Building tomorrow's antibody-drug conjugates (ADCs)

Companies similar to Araris Biotech AG

Synaffix logo — alternative to Araris Biotech AG

Synaffix

A Lonza Company

Spirea logo — alternative to Araris Biotech AG

Spirea

Elevating the Therapeutic Potential of ADCs in Cancer and Beyond with Our Unique Multivale...

Emergence Therapeutics logo — alternative to Araris Biotech AG

Emergence Therapeutics

Emergence Therapeutics creates effective immuno-therapeutics to target Nectin-4 and other...

VALANX Biotech logo — alternative to Araris Biotech AG

VALANX Biotech

Safer, more effective ADCs and protein-drug-conjugates with GoldenSite™ technology

Rival Readout

Competing with Araris Biotech AG? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout
NBE-Therapeutics AG logo — alternative to Araris Biotech AG

NBE-Therapeutics AG

Next generation antibody drug conjugates

Akari Therapeutics, Plc logo — alternative to Araris Biotech AG

Akari Therapeutics, Plc

Advancing Next-Generation Antibody Drug Conjugates Designed with Novel ImmunoOncology Payl...

Enara Bio logo — alternative to Araris Biotech AG

Enara Bio

Advancing cancer immunotherapy by targeting the unconventional

About Araris Biotech AG

Araris Biotech AG, founded in 2019 and headquartered in Switzerland, is at the forefront of biotechnology innovation with its focus on developing advanced antibody-drug conjugates (ADCs). The company's slogan, "Building tomorrow's antibody-drug conjugates (ADCs)", encapsulates its mission to revolutionize ADC technolog...

Services

Development of novel ADC linker technology, Generation of stable and potent ADCs, Research and development of next-generation ADCs

Target Customers

Pharmaceutical companies, Biotechnological companies, Oncology research institutions, Healthcare providers focusing on cancer treatment

Business keywords

Antibody-Drug Conjugates, Linker Technology, Novel Drug Development, Therapeutics, Payload Attachment, Off-the-Shelf Antibodies, Site-Specific Conjugation, Rapid Production, High-Quality Control, Patent-Backed Technology, Next-Generation ADCs, Safe And Potent Drugs, Biopharmaceutical Innovation

Business Model

B2B, API, Platform

Revenue Model

Licensing, Service Fee, Performance Based

Frequently Asked Questions

Companies similar to Araris Biotech AG include Synaffix, Spirea, Emergence Therapeutics, VALANX Biotech, NBE-Therapeutics AG. They work in Biotechnology and Health Care and share Araris Biotech AG's focus on antibody-drug conjugates and site-specific conjugation.
Bounce Watch lists 7 companies that share Araris Biotech AG's industries and are closest to it in business tags, services, target customers, business model and size.
Araris Biotech AG, founded in 2019 and headquartered in Switzerland, is at the forefront of biotechnology innovation with its focus on developing advanced antibody-drug conjugates (ADCs). The company's slogan, "Building tomorrow's antibody-drug conjugates (ADCs)", encapsulates its mission to revolutionize ADC technolog...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Araris Biotech AG: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at Araris Biotech AG on 11 Mar 2026. The 7 companies listed here were last checked between 4 Feb 2026 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout